Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-30

Clinical Trial Update: A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose safety and tolerability study of BMS-986166 in healthy volunteers; Ulcerative Colitis is listed as the associated condition and the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMS-986166

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED